Three new members were added to MedeFile International, Inc., these new Advisory Board members are former Healthcare Commissioner (NY State) Barbara DeBuono, Richard Farren, and Louis Hyman. Each of these members bring experience and something special to the team.
"In the midst of Health Care reform, we are extremely pleased and proud to add these remarkable individuals with years of experience and knowledge in the various fields of healthcare to our team," said Milton Hauser, CEO of MedeFile International. "MedeFile is committed to healthcare reform and is making significant strides to change the general public's image and knowledge of personal health records in today's society. We believe these new members of our advisory board will significantly help our team continue to develop opportunities and strategic planning within the personal health record market."
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
About MedeFile International, Inc.
Headquartered in South Florida, MedeFile has developed a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits. MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
